To further confirm the anti-tumorigenic activity of phenformin in vivo, the expression of Ki-67, cleaved caspase 3, VEGF, phosphorylated-AMPK and phosphorylated-S6 in the ovarian tumor tissues was evaluated by immunohistochemistry (Figure 6E). This evidence concerns the gene VEGFA and ovarian neoplasm.